Stocktoria
QTREX Quantum Ltd. QTEX
QTREX Quantum Ltd. (QTEX) earns a Piotroski F-score of 2/9 (weak financial health). It does not currently pay a dividend. FY2025 revenue was $289,000 at a -4574.4% net margin.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
Analyst price target
Wall Street analyst consensus — a sentiment gauge, not our scoring.
How it ranks in Manufacturing · percentile among 1957 companies
Percentile vs other Manufacturing companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 2/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Manufacturing companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| QTEX | QTREX Quantum Ltd. | 2/9 | — | — | — |
| PLSE | PULSE BIOSCIENCES, INC. | 2/9 | -10.11 | — | — |
| FOFA | FAMILY OFFICE OF AMERICA, INC. | 2/9 | -13.31 | — | — |
| SKYA | SkyAI, Inc. | 3/9 | — | — | — |
| LYRA | Lyra Therapeutics, Inc. | 2/9 | — | — | — |
| PAVM | PAVmed Inc. | 3/9 | — | 90.2 | — |
| RDGL | VIVOS INC | 2/9 | — | — | — |
About QTREX Quantum Ltd.
QTREX Quantum Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. It also offers HYLA blood sensor, which is designed to perform real-time sampling and analysis of key blood parameter measurements. The company was formerly known as Inspira Technologies Oxy B.H.N. Ltd. and changed its name to QTREX Quantum Ltd. in May 2026. QTREX Quantum Ltd. was incorporated in 2018 and is headquartered in Ra'anana, Israel.
FAQ
Is QTEX financially healthy?
QTREX Quantum Ltd.'s Piotroski F-score is 2/9 (8–9 is excellent, 0–3 weak).
Does QTEX pay a dividend?
No, QTREX Quantum Ltd. does not currently pay a dividend.
How profitable is QTEX?
In FY2025, QTREX Quantum Ltd. had a net margin of -4574.4% and a return on equity of -569.1%.
What is the analyst price target for QTEX?
The average Wall-Street price target for QTREX Quantum Ltd. is $5.00, about 395.0% above the recent price, from 1 analysts.
Is QTEX a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on QTREX Quantum Ltd.: a Piotroski F-score of 2/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.